Category - Executive Moves

Executive Moves

Former Pfizer vaccine president Nanette Cocero joins PharmaJet board

PharmaJet appointed Nanette Cocero, Ph.D., a recognized leader in the global pharmaceutical industry with broad commercial and business experience coupled with an extensive clinical and scientific background, to the...

July 12, 2023

Executive Moves

iBio names Dr. Martin Brenner and Felipe Duran as permanent CEO and CFO, respectively

iBio (NYSEA:IBIO) appointed Martin Brenner, DVM, Ph.D., as CEO and Felipe Duran as CFO, effective immediately. Dr. Brenner will also continue to serve as iBio’s CSO, a role he has held since December 2020. The...

June 27, 2023

Executive Moves

Marie Mazur appointed chair of PharmaJet board

PharmaJet named Marie Mazur, PharmD, chairwoman of the board, replacing Ron Lowy, who had chaired the board since 2011. “Marie’s experience and leadership will be of great benefit for our company as we are accelerating...

June 6, 2023

Executive Moves

Theralase appoints internationally accomplished biopharma Executive, Dr. Kaouthar Lbiati, as independent board director

Theralase Technologies (TSXV:TLT; OTCQB:TLTFF) appointed Kaouthar Lbiati, M.D., as an independent director. Dr. Lbiati received a post-doctorate in clinical oncology from Gustave Roussy Institute in Paris, which is a...

June 6, 2023

Executive Moves

Perimeter Medical names Adrian Mendes as CEO; appoints Dr. Josh Vose to board

The board of Perimeter Medical Imaging AI (TSXV:PINK; OTC:PYNKF; FSE:4PC) appointed Adrian Mendes as CEO, effective immediately, succeeding Jeremy Sobotta, who has resigned for personal reasons, effective June 15, 2023...

June 5, 2023

Executive Moves

Ondine Biomedical names Simon Sinclair as CMO

Ondine Biomedical (LON:OBI) appointed Simon Sinclair, M.D., Ph.D., as chief medical officer, as the company prepares to start a U.S. Phase 3 trial of its nasal photodisinfection technology. Dr. Sinclair has more than 20...

June 1, 2023

Executive Moves

Theralase names Roger DuMoulin-White as president and CEO

Theralase Technologies (TSXV:TLT; OTCQB:TLTFF) appointed Roger DuMoulin-White as president and CEO, succeeding Arkady Mandel, M.D., Ph.D., as interim CEO. Dr. Mandel will continue as CSO and a director. Mr. DuMoulin...

May 25, 2023

Executive Moves

Conavi Medical names CV device veteran Brian Chambless as CCO

Conavi Medical appointed accomplished cardiovascular medical device industry veteran, Brian Chambless, to the newly created position of chief commercial officer (CCO). In an executive management career spanning more...

May 15, 2023

Executive Moves

PharmaJet names Nathalie Landry as CSO

PharmaJet appointed Nathalie Landry as chief scientific officer to provide strategic leadership and ensure the company’s clinical and scientific programs align with its global commercial expansion. PharmaJet’s pipeline...

May 2, 2023

Executive Moves

Jeffrey Dayno named president, CEO of Harmony Biosciences

Harmony Biosciences (NASDAQ:HRMY) appointed Jeffrey Dayno, M.D., as president and CEO, and a member of the board. Dr. Dayno, a nationally recognized neuroscience expert, joined Harmony as CMO and EVP when the company...

April 24, 2023

Category - Executive Moves

Former Pfizer vaccine president Nanette Cocero joins PharmaJet board

iBio names Dr. Martin Brenner and Felipe Duran as permanent CEO and CFO, respectively

Marie Mazur appointed chair of PharmaJet board

Theralase appoints internationally accomplished biopharma Executive, Dr. Kaouthar Lbiati, as independent board director

Perimeter Medical names Adrian Mendes as CEO; appoints Dr. Josh Vose to board

Ondine Biomedical names Simon Sinclair as CMO

Theralase names Roger DuMoulin-White as president and CEO

Conavi Medical names CV device veteran Brian Chambless as CCO

PharmaJet names Nathalie Landry as CSO

Jeffrey Dayno named president, CEO of Harmony Biosciences

General

More